2025-04-25 23:05:33
Latest Post
Mahindra Lifespace Developers Ltd Q4FY25 consolidated PAT climbs to Rs. 85.08 crores
Zensar Technologies Ltd consolidated Q4 FY2024-25 net profit increases to Rs. 176.4 crores
Sasken Technologies Ltd consolidated PAT for Q4FY25 increases QoQ to Rs. 11.02 crores
Aurum PropTech Ltd Q4FY25 consolidated loss at Rs. 7.20 crores
Tejas Networks Ltd reports consolidated loss of Rs. 71.80 crores in Q4 FY2024-25
Stock Report
India Glycols Limited receives EIR from USFDA for Dehradun Plant
Posted On : 2025-04-25 20:28:07( TIMEZONE : IST )
India Glycols Limited has received the Establishment Inspection Report (EIR) with no observation from US Food and Drug Administration (USFDA) on 24th April, 2025 for the Company's nutraceutical products and dietary supplements ingredients at Dehradun Plant.
The receipt of EIR underscores the Company's commitment to adhering to global quality standards and paves the way for access to the premium U.S. market, along with other highly regulated global markets.
Shares of India Glycols Limited was last trading in BSE at Rs. 1419.85 as compared to the previous close of Rs. 1409.40. The total number of shares traded during the day was 5877 in over 615 trades.
The stock hit an intraday high of Rs. 1444.95 and intraday low of 1392.20. The net turnover during the day was Rs. 8298709.00.
